NRx Pharmaceuticals Inc.
NRXP | NASDAQ
$3.29
-$0.03 (-0.90%)
At close: Sep 21, 2026, 4:00 PM ET
$3.29
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:39 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.02 | -0.92 | -1.16 | -18.50 | -6.42 | -161.59 |
PEG Ratio | 0.05 | 0.02 | 0 | 0.20 | -0.02 | 0.56 |
PS Ratio | 47.35 | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -3.64 | -1 | -2.97 | 98.53 | 107.79 | -3.05 |
P/FCF Ratio | -4.11 | -2.18 | -1.61 | -18.36 | -59.47 | -58.83 |
P/OCF Ratio | -4.11 | -2.18 | -1.61 | -18.36 | -59.48 | -58.88 |
OCF/S Ratio | -1.15K | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.04 | -0.28 | -0.78 | 1.42 | 0.02 | -0.02 |
Quick Ratio | 0.31 | 0.15 | 0.36 | 1.66 | 2.74 | 0.06 |
Current Ratio | 0.31 | 0.15 | 0.36 | 1.66 | 2.74 | 0.06 |
Asset Turnover | 0.09 | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -24.18 | -18.26 | -229.89 | n/a | -5.29K | -393.95 |
Return on Equity | 179.59% | 108.19% | 256.97% | -536.56% | -447.29% | 118.29% |
Return on Assets | -220.92% | -688.20% | -412.17% | -153.99% | -284.34% | -1.76K% |
Return on Invested Capital | 106% | 118.37% | 1.07K% | -247.21% | -446.45% | 51.34% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 58.78% | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -2.34K% | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -2.34K% | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -1.32K% | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -1.15K% | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -2.27K% | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NRXP